Toth Financial Advisory’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $309K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $38.1K | Hold |
|
|||||
|
2024
Q1 | $38.9K | Sell |
|
|||||
|
2023
Q4 | $45.3K | Sell |
|
|||||
|
2023
Q3 | $52.1K | Hold |
|
|||||
|
2023
Q2 | $68K | Hold |
|
|||||
|
2023
Q1 | $69.3K | Hold |
|
|||||
|
2022
Q4 | $65.5K | Sell |
|
|||||
|
2022
Q3 | $97K | Hold |
|
|||||
|
2022
Q2 | $106K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Buy |
|
|||||
|
2021
Q4 | $68K | Hold |
|
|||||
|
2021
Q3 | $63K | Hold |
|
|||||
|
2021
Q2 | $69K | Sell |
|
|||||
|
2021
Q1 | $1.32M | Buy |
|
|||||
|
2020
Q4 | $1.05M | Buy |
|
|||||
|
2020
Q3 | $888K | Buy |
|
|||||
|
2020
Q2 | $773K | Buy |
|
|||||
|
2020
Q1 | $62K | Buy |
|